Jea Yu, Contributing Author at MarketBeat Articles by Jea Yu - Page 29January 23, 2024 5:25 AM ETWhich stock is a one-stop shop for outdoor lifestyles?Jea YuOutdoor products and lifestyle manufacturer Vista Outdoor Inc. (NASDAQ: VSTO) may not be a familiar name, but its portfolio of brands is. NYSE:VSTONYSE:DKSOTC:CZGZFRead Which stock is a one-stop shop for outdoor lifestyles?January 23, 2024 5:21 AM ETSarepta Therapeutics Inc.: Why it's a rising gene therapy starJea YuSarepta Therapeutics Inc. (NASDAQ: SRPT) is a leading commercial-stage biotech focused on developing precision gene therapy treatments for rare diseases. NASDAQ:SRPTNYSE:PFENASDAQ:WVERead Sarepta Therapeutics Inc.: Why it's a rising gene therapy starJanuary 23, 2024 4:18 AM ETThe Coty turnaround can accelerate in 2024Jea YuGlobal beauty products maker Coty Inc. has been in a turnaround that looks to accelerate in 2024 as the company rides the medicated beauty trendNYSE:COTYNYSE:ELNYSE:ELFRead The Coty turnaround can accelerate in 2024January 23, 2024 4:12 AM ETCould CAVA Group be the Chipotle of Mediterranean food?Jea YuMediterranean fast-casual restaurant operator CAVA Group Inc. (NASDAQ: CAVA) is often compared to Chipotle Mexican Grill Inc. (NYSE: CMG), as customers also NYSE:CAVANYSE:CMGNYSE:SGRead Could CAVA Group be the Chipotle of Mediterranean food?January 22, 2024 5:39 AM ETIs Applied Digital’s 35% stock plunge an AI buying opportunity?Jea YuApplied Digital Co. (NASDAQ: APLD) shares experienced a 4X surge in 2023, riding the artificial intelligence (AI) trend as a provider of next-generation AI NASDAQ:APLDNYSE:HPENASDAQ:EQIXRead Is Applied Digital’s 35% stock plunge an AI buying opportunity?January 17, 2024 5:00 AM ETMedtronic receives FDA approval for deep brain stimulation systemJea YuMedical device maker Medtronic PLC (NYSE: MDT) received U.S. FDA approval for its implantable medical device called the Percept PC Deep Brain Stimulation (DBS) NYSE:MDTNYSE:ABTRead Medtronic receives FDA approval for deep brain stimulation systemJanuary 17, 2024 5:00 AM ETSolo Brands cooked on 2023 guidance cut. Is it a bargain or trap? Jea YuOutdoor and lifestyle products maker Solo Brands Inc. (NASDAQ: DTC) has grown a cult like following under its many brands. This consumer discretionary sector NYSE:DTCNYSE:DKSNYSE:VSTORead Solo Brands cooked on 2023 guidance cut. Is it a bargain or trap? January 16, 2024 7:00 AM ETTime to buy these 3 healthcare companies that raised revenue guidance?Jea YuThe new year brings a clean slate heading into the fourth-quarter earnings season. Check out a few companies that have raised revenue guidance.NASDAQ:EXASNASDAQ:HOLXNASDAQ:FOLDRead Time to buy these 3 healthcare companies that raised revenue guidance?January 16, 2024 5:48 AM ETSurgery Partners feeling no pinch from macroeconomic weaknessJea YuSurgery Partners Inc. (NASDAQ: SGRY) is a leading healthcare services provider that owns and operates over 180 outpatient surgical centers in 31 states. NASDAQ:SGRYNYSE:HCARead Surgery Partners feeling no pinch from macroeconomic weaknessJanuary 16, 2024 5:43 AM ETZIM Shipping stock proves unsinkable despite Red Sea disruptionsJea YuThe Houthi attacks on cargo ships in the Red Sea have caused widespread disruptions and economic ramifications for the transportation sector with cargo NYSE:ZIMNASDAQ:TSLANYSE:NMMRead ZIM Shipping stock proves unsinkable despite Red Sea disruptionsJanuary 16, 2024 5:00 AM ETQuantumScape surges on solid-state EV battery: Hype or home run? Jea YuQuantumScape Co. (NYSE: QS) has been developing the next-generation solid-state lithium-metal batteries for electric vehicles (EV). Learn more.NYSE:QSNYSE:FOTCMKTS:VWAGYRead QuantumScape surges on solid-state EV battery: Hype or home run? January 16, 2024 5:00 AM ET 2 biotechs with promising weight-loss drugs comingJea YuClinical weight-loss medications have been making headlines as GLP-1 drugs like Novo Nordisk A/S (NYSE: NVO) owned Ozempic and Wegovy and Eli Lilly and Co.NASDAQ:VKTXNASDAQ:RYTMNYSE:LLYRead 2 biotechs with promising weight-loss drugs comingJanuary 16, 2024 5:00 AM ETAffordable networking stocks to watch on the Juniper buyoutJea YuNetwork communications equipment provider Juniper Networks Inc. (NASDAQ: JNPR) is being acquired by Hewlett Packard Enterprise Co. (NYSE: HPE) for NASDAQ:EXTRNASDAQ:INFNNYSE:JNPRRead Affordable networking stocks to watch on the Juniper buyoutJanuary 15, 2024 7:59 AM ETLululemon stock falls on raised guidanceJea YuPremium athleisure brand Lululemon Athletica Inc. (NASDAQ: LULU) entered the holiday shopping season with solid momentum, sending shares through its all-time NASDAQ:LULUNYSE:UAANYSE:NKERead Lululemon stock falls on raised guidanceJanuary 11, 2024 7:45 AM ETHow to trade options if you believe a big price move is coming Jea YuIf you believe that a stock in any stock sector will make a large price move, you can make an options trade called a straddle to capitalize on the anticipated NASDAQ:INTCRead How to trade options if you believe a big price move is coming January 9, 2024 5:18 AM ETMobileye gets poked on weak forecasts, buying opportunityJea YuAdvanced driver assistance systems (ADAS) and autonomous driving technology provider Mobileye Global Inc. (NASDAQ: MBLY) shocked investors when it unexpectedly NASDAQ:MBLYNYSE:GMNYSE:FRead Mobileye gets poked on weak forecasts, buying opportunityJanuary 9, 2024 5:00 AM ETPinterest: The frictionless social commerce play for 2024Jea YuPinterest is back in the black, earning a GAAP net income of $7 million and adjusted EBITDA of $185 million in Q3 2023.NYSE:PINSNASDAQ:METANYSE:SNAPRead Pinterest: The frictionless social commerce play for 2024January 9, 2024 4:30 AM ETIs EchoStar a buy after the Dish Network buyout?Jea YuSatellite network operator EchoStar completed its merger with DISH Network, but investors wonder if this will help or hurt EchoStarNASDAQ:SATSNASDAQ:DISHNASDAQ:TMUSRead Is EchoStar a buy after the Dish Network buyout?January 9, 2024 4:20 AM ETAugmedix is an ambient AI healthcare optimization playJea YuAugmedix is using ambient AI in an effort to transform doctor-patient conversations to improve workflows and improve the accuracy of medical records NASDAQ:AUGXNYSE:HCANASDAQ:GOOGLRead Augmedix is an ambient AI healthcare optimization playJanuary 9, 2024 4:16 AM ETCan Simply Good Foods ride the GLP-1 weight loss trend in 2024?Jea YuSimply Good Foods may be ready to breakout as the GLP-1 medication weight-loss trend is driving up sales for its Atkins and Quest Nutrition branded productsNASDAQ:SMPLNYSE:BRBRNYSE:NVORead Can Simply Good Foods ride the GLP-1 weight loss trend in 2024?January 9, 2024 4:06 AM ETSprinklr: Has the smoke cleared to buy back in? Jea YuSprinklr offers a cloud-based unified customer experience management platform with a solid base of valuable brands to drive revenue and earningsNYSE:CXMNASDAQ:MARNASDAQ:MSFTRead Sprinklr: Has the smoke cleared to buy back in? January 8, 2024 7:24 AM ETVoyager Therapeutics stock pops 30% on deal with Novartis Jea YuVoyager Therapeutics Inc. (NASDAQ: VYGR) is a biotech in the medical sector that specializes in gene therapy for neurological diseases. Its shares took NASDAQ:VYGRNYSE:NVSNASDAQ:NTLARead Voyager Therapeutics stock pops 30% on deal with Novartis January 8, 2024 6:26 AM ET2 low-priced gene therapy stocks to speculate onJea YuGene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic diffe NASDAQ:BLUENASDAQ:SGMONASDAQ:VRTXRead 2 low-priced gene therapy stocks to speculate onJanuary 8, 2024 5:00 AM ETClearwater Analytics: An affordable, best-of-breed SaaS playJea YuClearwater Analytics Holdings Inc. (NASDAQ: CWAN) is a leading investment accounting, reporting and management platform in the business services sector. NYSE:CWANNASDAQ:METANASDAQ:FITBRead Clearwater Analytics: An affordable, best-of-breed SaaS play Page 29 of 92 « Most Recent‹ More Recent26272829303132 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
